Premium
Resistance Training Improves Cardiovascular Risk Factors in Obese Women Despite a Significative Decrease in Serum Adiponectin Levels
Author(s) -
Ibáñez Javier,
Izquierdo Mikel,
MartínezLabari Cristina,
Ortega Francisco,
Grijalba Ana,
Forga Luis,
Idoate Fernando,
GarcíaUnciti Marisol,
FernándezReal José M.,
Gorostiaga Esteban M.
Publication year - 2010
Publication title -
obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.438
H-Index - 199
eISSN - 1930-739X
pISSN - 1930-7381
DOI - 10.1038/oby.2009.277
Subject(s) - adiponectin , medicine , insulin resistance , endocrinology , weight loss , obesity , body mass index , insulin , insulin sensitivity
Increased circulating adiponectin and insulin sensitivity are usually observed after body fat loss induced by a weight‐loss diet. Progressive resistance training (PRT) without a concomitant weight‐loss diet significantly decreases visceral fat, thus improving insulin sensitivity. Therefore, the purpose of this study was to ascertain the effects of combined 16‐week PRT and weight‐loss diet on circulating adiponectin and insulin sensitivity index. Thirty‐four obese (BMI: 30–40 kg/m 2 ) women, aged 40–60 year, were randomized to three groups: a control group (C; n = 9); a diet group (WL; n = 12) with a caloric restriction of 500 kcal/d; and a diet plus resistance training group (WL+RT; n = 13) with the same caloric restriction as group WL and a 16‐week supervised whole body PRT of two sessions/week. Both WL and WL+RT groups showed similar decreases in body mass (−6.3% and −7.7%) and visceral fat (−19.9% and −20.5%). WL resulted in an expected increase in circulating levels of adiponectin ( P = 0.07) and insulin sensitivity. However, circulating total adiponectin decreased ( P < 0.05) in WL+RT group, whereas an improvement in different cardiovascular risk factors (insulin sensitivity, low‐density lipoprotein cholesterol (LDL‐C), etc.) was observed. In conclusion, in obese women a 16‐week combined PRT and weight‐loss diet is accompanied by significant improvements in different cardiovascular risk factors in spite of a significant decrease of circulating adiponectin.